Nova Vita Laboratories | Advanced Regenerative Medicine & Amniotic Fluid Therapeutics

Working within regulatory frameworks allows our scientists and clinical research partners to operate with integrity.

Minimal manipulation processing method

No culturing or expansion

No genetic modification

We require our clinical partners to collect outcome data with patients to validate clinical approaches. Our research is grounded in a respect for clinical practice and patient outcomes.

Our collaborations with medical researchers and medical service organizations drive our mission forward. We are working towards several INDs in a variety of clinical arenas.

High concentration of nanoparticles

Nanoparticle composition includes: extracellular vesicles (exosomes), growth factors, cytokines, chemokine, peptides, amino acids, and hyaluronic acid

Regulatory Compliance

Our commitment to regulatory compliance ensures our innovations move seamlessly from research to clinical application, maintaining the highest standards of patient safety.

Our processes strictly adhere to minimal manipulation and homologous use guidelines, establishing a foundation of trust and reliability.

Clinical Partnerships

We forge strategic partnerships with leading regenerative medicine doctors and scientists who share our commitment to excellence and transparency.

These collaborations focus on rigorous data collection and analysis, ensuring our therapeutic developments are backed by solid scientific evidence.

Product Quality

Our product development philosophy centers on three principles: safety, efficacy, and compliance. With research and development, we advance the field of regenerative medicine.

Our sound data collection methods and advanced R&D processes enable continuous improvement and validation of our therapeutic solutions.

“Our mission is to disrupt traditional medical markets by developing safe, effective, and regulatory compliant regenerative medicines with multiple indications validated through investigational new drug trials.”

David Crane MD

Chief Executive Officer

Our team combines decades of expertise in sports medicine, molecular biology, proteomics research, and therapeutic development. This multidisciplinary approach bridges the gap between scientific innovation and clinical application.

Meet Our Team

Pioneering Novel Messaging Therapies

Through data-driven analysis and clinical partnerships, we are discovering new, compliant, therapeutic treatments.

The Nova Vita Difference

Our Team

Articles and News